Soru

Zorluk: KolayBipolar and Related Disorders

A 22-year-old man visits a community health clinic reporting a 3-week period of severely depressed mood, hypersomnia, and intense feelings of worthlessness. During the psychiatric history, the physician learns that one year ago, the patient experienced a distinct 10-day period where he felt 'invincible,' required only 3 hours of sleep per night to feel fully rested, and engaged in impulsive, high-risk financial investments. He currently takes no medications and has no other medical conditions. Which of the following represent appropriate initial management steps for this patient's current condition? (Select all that apply)

  1. Initiate quetiapine monotherapyCevap
  2. Initiate lurasidone monotherapyCevap
  3. C
    Initiate sertraline monotherapy
  4. D
    Initiate venlafaxine monotherapy
  5. E
    Initiate a combination of fluoxetine and phenelzine

Cevap

The appropriate initial management steps include initiating quetiapine monotherapy or initiating lurasidone monotherapy.
The patient is experiencing an acute major depressive episode and has a history of a distinct manic episode, establishing a diagnosis of bipolar I disorder. For acute bipolar depression, first-line FDA-approved monotherapies include second-generation antipsychotics such as quetiapine and lurasidone. These agents effectively target depressive symptoms without significantly increasing the risk of inducing a manic switch.

Adım Adım Çözüm

1
Identify the nature of the current episode.
The patient has had 3 weeks of severely depressed mood, hypersomnia, and worthlessness, indicating a Major Depressive Episode.
Establishing the current affective state is necessary to guide acute management.
2
Analyze the past psychiatric history.
The patient experienced a 10-day period of feeling invincible, decreased need for sleep, and impulsivity, which meets the criteria for a Manic Episode.
A history of mania fundamentally changes the diagnosis and treatment approach from unipolar depression.
3
Establish the overarching diagnosis.
The combination of a past manic episode and a current major depressive episode yields a diagnosis of Bipolar I Disorder, current episode depressed.
Correct diagnosis is critical to avoid prescribing contraindicated medications.
4
Select appropriate pharmacotherapy for bipolar depression.
Quetiapine and lurasidone are selected because they are FDA-approved first-line monotherapies for bipolar depression.
These atypical antipsychotics safely treat depression in bipolar patients without carrying the high risk of manic switching associated with traditional antidepressants.

Anahtar Kavram

Patients presenting with depressive symptoms must be screened for a history of mania; if bipolar depression is diagnosed, it should be treated with first-line agents like quetiapine or lurasidone, while avoiding antidepressant monotherapy to prevent a manic switch.
Bu soruyu puanla